Company profile for Io Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Io Therapeutics develops retinoid and rexinoid small molecules to treat cancer, neurodegenerative, and autoimmune diseases. Their lead program, IRX4204, targets HER2-positive breast cancer, Parkinson’s, Alzheimer’s, and inflammatory conditions. A second program, IRX5183, focuses on multiple myeloma and acute myeloid leukemia. They also explore novel small molecules to enhance anti-cancer responses.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
9450 Pinecroft Dr, Unit 9497 Spring, Texas 77387
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/06/3201050/0/en/Io-Therapeutics-presents-today-at-the-American-Society-for-Hematology-Annual-Meeting-preclinical-studies-demonstrating-combination-treatment-with-BCMA-CAR-T-cells-plus-the-company-.html

GLOBENEWSWIRE
06 Dec 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty